Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Arginine and Metformin in Duchenne Muscular Dystrophy
NCT02516085Phase 1Completed
- Sponsor
- University Hospital Basel
- Start
- Jan 2012
- Primary completion
- Oct 2012
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of arginine and metformin in Duchenne muscular dystrophy (DMD), sponsored by University Hospital Basel. Primary endpoint: Mean change of muscle metabolism at 16 weeks. Started Jan 2012; status: completed.
02
Drugs
argininemetformin
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT02516085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02516085.